P53 Expression is Rare in Cutaneous Melanomas
Overview
Affiliations
Alterations in the tumor-suppressor gene p53 are common in many types of human malignancies, but the potential role of p53 in the pathogenesis of cutaneous melanoma is controversial. The gene product, p53 protein, is normally present in very small amounts in noncancerous tissues. Missense mutations lead to accumulation of mutant p53 in the cells, which makes it detectable immunohistochemically in many cancers. Formalin-fixed, paraffin-embedded sections of 14 primary invasive melanomas, 3 cutaneous melanoma metastases, and 10 predominantly intradermal melanocytic nevi were reacted with a panel of three anti-p53 monoclonal antibodies (mAbs) (PAb240, PAb1801, and DO7) and a mAb against Ki-67 (MIB-1), a marker of cellular proliferation. p53 was not detected in morphologically normal epidermal melanocytes or nevus cells. A single primary invasive melanoma, having a very high index of proliferation (Ki-67 expression in > 50% of cells), had diffuse nuclear labeling with all three anti-p53 mAbs used. Abnormalities of p53 expression occur rarely in cutaneous melanomas, but overexpression of p53 may occur in a subset of melanomas with a high index of proliferation.
The gene predicts prognosis and response to chemotherapy in epithelial ovarian cancer.
Li X, Hua T, Li Y, Tian Y, Huo Y, Kang S Ann Transl Med. 2021; 9(9):806.
PMID: 34268419 PMC: 8246186. DOI: 10.21037/atm-21-2087.
Margolin K, Longmate J, Synold T, Gandara D, Weber J, Gonzalez R Invest New Drugs. 2001; 19(4):335-40.
PMID: 11561695 DOI: 10.1023/a:1010626230081.
Human papilloma virus in melanoma biopsy specimens and its relation to melanoma progression.
Dreau D, Culberson C, Wyatt S, Holder Jr W Ann Surg. 2000; 231(5):664-71.
PMID: 10767787 PMC: 1421053. DOI: 10.1097/00000658-200005000-00006.
Oka H, Kameya T, Hata T, Kawano N, Fujii K, Yada K J Neurooncol. 1999; 44(1):41-5.
PMID: 10582667 DOI: 10.1023/a:1006127619926.
Okamoto I, Pirc-Danoewinata H, Ackermann J, Drach J, Schlagbauer Wadl H, Jansen B Br J Cancer. 1999; 79(1):131-7.
PMID: 10408704 PMC: 2362169. DOI: 10.1038/sj.bjc.6690022.